Used in biomedical research to quantify levels of Transmembrane Protein 39A in cell lysates, tissue extracts, and biological fluids. Enables investigation of TMEM39A's role in autoimmune diseases such as systemic lupus erythematosus and multiple sclerosis, where dysregulation of this protein has been implicated. Supports studies on endoplasmic reticulum morphology, autophagy, and vesicular trafficking by providing a reliable method to measure protein expression under different experimental conditions. Commonly used in immunology and cell biology labs for high-throughput screening and validation of gene function in disease models.